美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

DAMORA THERAPEUT

23.05

+4.9127.07%

盘前：22.86-0.1900-0.82%08:57 EDT

成交量：33.79万

成交额：718.94万

市值：13.89亿

市盈率：-0.15

高：23.18

开：17.81

低：17.66

收：18.14

52周最高：38.33

52周最低：2.01

股本：6,024.01万

流通股本：5,114.08万

量比：0.72

换手率：0.66%

股息：- -

股息率：- -

每股收益(TTM):-153.9532

每股收益(LYR):-18.5274

净资产收益率：-163.80%

总资产收益率：-16.46%

市净率：-7.90

市盈率(LYR):-1.24

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

DAMORA THERAPEUT

交易所：

NASDAQ

成立时间：

2011

员工人数：

5

公司地址：

Building 23,Suite 105,221 Crescent Street,Waltham,Massachusetts,United States

官网：

http://www.damoratx.com

邮编：

02453

电话：

传真：

- -

简介：

Damora Therapeutics, Inc.于2019年10月在特拉华州注册成立，是一家专注于重新定义血液系统疾病患者治疗方案的创新型生物技术公司。该公司正在推进新一代生物制剂的研发，旨在治疗突变钙网蛋白驱动的骨髓增生性肿瘤，包括原发性血小板增多症和骨髓纤维化，这些疾病亟需能够改善病情的治疗方案。Damora的多个项目展现出同类最佳的潜力，并计划于2026年进入临床开发阶段。公司的目标是快速推出优化疗法，这些疗法不仅覆盖广泛的突变类型，而且使用极其便捷，最终目标是显著改善患者的治疗效果。

董事

名称

职位

Carl Goldfischer

Director and Chair of the Board

Amit D. Munshi

Director

Chris Cain

Director

Jayson Dallas

Director

Julianne Bruno

Director

Peter Harwin

Director

股东

名称

职位

Sherwin Sattarzadeh

Chief Operating Officer and Interim Principal Executive Officer

Lori Firmani

Interim Chief Financial Officer

Garrett Winslow

General Counsel

Matthew Kronmiller

Executive Vice President of Strategy and Chief Business Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DMRA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","market":"US","secType":"STK","nameCN":"DAMORA THERAPEUT","latestPrice":23.05,"timestamp":1774296000000,"preClose":18.14,"halted":0,"volume":337881,"hourTrading":{"tag":"盘前","latestPrice":22.86,"preClose":23.05,"latestTime":"08:57 EDT","volume":157,"amount":3600.224462,"timestamp":1774357033113,"change":-0.19,"changeRate":-0.008243,"amplitude":0.010846},"delay":0,"changeRate":0.27067254685777287,"floatShares":51140800,"shares":60240100,"eps":-153.95322,"marketStatus":"盘前交易","change":4.91,"latestTime":"03-24 09:16:23 EDT","open":17.81,"high":23.18,"low":17.655,"amount":7189378.870683,"amplitude":0.304576,"askPrice":28.01,"askSize":800,"bidPrice":17.36,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-153.95322,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":23.05,"preHourTrading":{"tag":"盘前","latestPrice":22.86,"preClose":23.05,"latestTime":"08:57 EDT","volume":157,"amount":3600.224462,"timestamp":1774357033113,"change":-0.19,"changeRate":-0.008243,"amplitude":0.010846},"postHourTrading":{"tag":"盘后","latestPrice":23.1644,"preClose":23.05,"latestTime":"19:10 EDT","volume":667,"amount":15430.0055,"timestamp":1774307401144,"change":0.1144,"changeRate":0.004963,"amplitude":0.004963},"volumeRatio":0.7245136542319823},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","floatShares":51140800,"roa":"-16.46%","roe":"-163.80%","lyrEps":-18.527432,"volumeRatio":0.7245136542319823,"shares":60240100,"dividePrice":0,"high":23.18,"amplitude":0.304576,"preClose":18.14,"low":17.655,"week52Low":2.01,"pbRate":"-7.90","week52High":38.3251,"institutionHeld":0,"latestPrice":23.05,"eps":-153.95322,"divideRate":0,"volume":337881,"delay":0,"ttmEps":-153.95322,"open":17.81,"prevYearClose":23.01,"prevWeekClose":18.14,"prevMonthClose":29.58,"prevQuarterClose":23.01,"fiveDayClose":24.98,"twentyDayClose":29.78,"sixtyDayClose":29.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"DMRA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"DMRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-2.36},{"market":"US","date":"2025-08-05","symbol":"DMRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-2.6},{"market":"US","date":"2025-05-08","symbol":"DMRA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-1.92},{"market":"US","date":"2025-03-19","symbol":"DMRA","fiscalQuarterEnding":"2024/12","expectedEps":-3.12,"name":null,"time":"盘后","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":-5.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1771387200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMRA","date":"2026-03-23","current":-0.149721,"percent":1,"low":-100.260711,"twenty":-100.169461,"median":-94.975827,"eighty":-77.448262,"high":-5.207587,"avg":-82.500658,"sd":28.776013,"marketCap":1092754906},"quantilePoints":[{"date":"2026-03-13","current":-100.260711,"twenty":-100.260711,"median":-100.260711,"eighty":-98.29884,"marketCap":1588530698},{"date":"2026-03-20","current":-72.999835,"twenty":-100.199878,"median":-95.983376,"eighty":-84.763454,"marketCap":1156609382},{"date":"2026-03-23","current":-5.207587,"twenty":-100.169461,"median":-94.975827,"eighty":-77.448262,"marketCap":1092754906}],"updateTime":1774352141339},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":154090027,"yearFounded":2011,"employeeNum":5,"address":"Building 23,Suite 105,221 Crescent Street,Waltham,Massachusetts,United States","zipCode":"02453","officePhone":"781 281 9020"},"stockCompanyDetail":{"websiteUrl":"http://www.damoratx.com","stockEarnings":[{"period":"1week","weight":-0.0773},{"period":"1month","weight":-0.2317},{"period":"3month","weight":-0.2074},{"period":"6month","weight":4.4108},{"period":"1year","weight":2.7787},{"period":"ytd","weight":0.0017}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Damora Therapeutics, Inc.于2019年10月在特拉华州注册成立，是一家专注于重新定义血液系统疾病患者治疗方案的创新型生物技术公司。该公司正在推进新一代生物制剂的研发，旨在治疗突变钙网蛋白驱动的骨髓增生性肿瘤，包括原发性血小板增多症和骨髓纤维化，这些疾病亟需能够改善病情的治疗方案。Damora的多个项目展现出同类最佳的潜力，并计划于2026年进入临床开发阶段。公司的目标是快速推出优化疗法，这些疗法不仅覆盖广泛的突变类型，而且使用极其便捷，最终目标是显著改善患者的治疗效果。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.139908},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.041874},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.124567},{"month":4,"riseRate":0,"avgChangeRate":-0.128225},{"month":5,"riseRate":0.4,"avgChangeRate":-0.011355},{"month":6,"riseRate":0.6,"avgChangeRate":0.064068},{"month":7,"riseRate":0.4,"avgChangeRate":0.030923},{"month":8,"riseRate":0.4,"avgChangeRate":-0.123358},{"month":9,"riseRate":0.6,"avgChangeRate":0.012323},{"month":10,"riseRate":0.4,"avgChangeRate":0.0502},{"month":11,"riseRate":0.5,"avgChangeRate":0.174574},{"month":12,"riseRate":0.5,"avgChangeRate":-0.010261}],"exchange":"NASDAQ","name":"DAMORA THERAPEUT","nameEN":"DAMORA THERAPEUT"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":{"directors":[{"name":"Carl Goldfischer","position":"Director and Chair of the Board"},{"name":"Amit D. Munshi","position":"Director"},{"name":"Chris Cain","position":"Director"},{"name":"Jayson Dallas","position":"Director"},{"name":"Julianne Bruno","position":"Director"},{"name":"Peter Harwin","position":"Director"}],"executives":[{"name":"Sherwin Sattarzadeh","position":"Chief Operating Officer and Interim Principal Executive Officer"},{"name":"Lori Firmani","position":"Interim Chief Financial Officer"},{"name":"Garrett Winslow","position":"General Counsel"},{"name":"Matthew Kronmiller","position":"Executive Vice President of Strategy and Chief Business Officer"}]}}}